# Junta clínica — PT-pseudo_20ba3f0f6ca0 (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_20ba3f0f6ca0",
  "pid": "PT-pseudo_20ba3f0f6ca0",
  "task": 1,
  "psa": 4.8,
  "age": 65,
  "months": 3,
  "pirads": "4",
  "psad": 0.086,
  "psav": 0.35,
  "psap": 3.8,
  "vol": 56.0,
  "dre": "Nodus",
  "bx": "None",
  "cspca": 0.7257912,
  "medhx": "Not reported",
  "meds": "None",
  "notes": "PSA 4.8 ng/mL. PI-RADS 4. PSAD 0.09. Prostate volume 56 mL. DRE nodus. csPCa 0.73.",
  "pmhx": [],
  "allergies": [],
  "vitals": {
    "weight": "76 kg",
    "height": "188 cm",
    "bmi": "21.5",
    "bp": "131/58 mmHg",
    "hr": "71 bpm",
    "smoking": "Ex-smoker (11 pack-yr, quit 2023)",
    "last_dental": "6 mo ago",
    "flu_vax": "Sep 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "01 Jan 2025",
  "enc_ref": "Dr. C. Peters (GP)",
  "enc_type": "Follow-up - PSA + MRI",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "A recent elevation of prostate-specific antigen to 4.8 ng/mL, coupled with a multiparametric MRI conducted at Jeroen Bosch Ziekenhuis, prompted this consultation."
    },
    {
      "s": "History",
      "t": "A semi-retired musician with a smoking history of 11 pack-years (cessation in 2023) seeks evaluation for a progressively rising PSA and recent imaging results. He reports zero lower urinary tract symptoms, denies haematuria, bone pain, or unexplained weight loss, and maintains a daily 45-minute walking routine alongside a modest alcohol intake of roughly 2 units weekly. Following a recent move, he now shares a residence with his sister, who acts as his next of kin, while his marital status remains married though he currently lives apart from his spouse. Past medical encounters include a routine audiology assessment for mild hearing loss and a dermatology visit for actinic keratosis surveillance; otherwise, his health history is clear, with no comorbidities and no active medications. His prior biopsy bucket remains None. He relies on written summaries during consultations due to mild hearing impairment."
    },
    {
      "s": "Physical examination",
      "t": "DRE — texture: firm, mobility: unrestricted, asymmetry: Nodus palpable in the right mid-gland peripheral zone. Abdominal and cardiovascular assessments show no abnormalities, recording a blood pressure of 131/58 mmHg and a regular heart rate of 71 bpm. Peripheral lymphadenopathy and hepatosplenomegaly are absent."
    }
  ],
  "occupation": "musician (semi-retired)",
  "marital": "Married",
  "living": "Recently relocated; lives with sister",
  "next_of_kin": "Sibling (sister)",
  "recent_other": [
    "Audiology — hearing test",
    "Dermatology — actinic keratosis check"
  ],
  "alcohol": "2 units / week",
  "exercise": "Walking 45 min/day",
  "ipss": "IPSS score: 0/35 (mild LUTS)",
  "admin": "Hard of hearing — speak clearly; prefers written summaries.",
  "mri_hospital": "Jeroen Bosch Ziekenhuis ('s-Hertogenbosch)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_20ba3f0f6ca0
Task: 1

Encounter: Urology - outpatient on 01 Jan 2025.
Referrer: Dr. C. Peters (GP).
Type: Follow-up - PSA + MRI.

Clinical data (read-only — values loaded from the record):
  - 65-year-old male
  - PSA: 4.8 ng/mL
  - mpMRI — PI-RADS score: 4 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.086 ng/mL²
  - PSA velocity: 0.35 ng/mL/yr
  - Prior PSA: 3.8 ng/mL
  - Prostate volume: 56.0 mL
  - Months since last PSA: 3
  - DRE findings: Nodus (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: None (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.7257912 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NKA
  - Additional notes: PSA 4.8 ng/mL. PI-RADS 4. PSAD 0.09. Prostate volume 56 mL. DRE nodus. csPCa 0.73.

Vitals: weight 76 kg, height 188 cm, BMI 21.5, BP 131/58 mmHg, HR 71 bpm. Smoking: Ex-smoker (11 pack-yr, quit 2023).

Chief complaint: A recent elevation of prostate-specific antigen to 4.8 ng/mL, coupled with a multiparametric MRI conducted at Jeroen Bosch Ziekenhuis, prompted this consultation.

History: A semi-retired musician with a smoking history of 11 pack-years (cessation in 2023) seeks evaluation for a progressively rising PSA and recent imaging results. He reports zero lower urinary tract symptoms, denies haematuria, bone pain, or unexplained weight loss, and maintains a daily 45-minute walking routine alongside a modest alcohol intake of roughly 2 units weekly. Following a recent move, he now shares a residence with his sister, who acts as his next of kin, while his marital status remains married though he currently lives apart from his spouse. Past medical encounters include a routine audiology assessment for mild hearing loss and a dermatology visit for actinic keratosis surveillance; otherwise, his health history is clear, with no comorbidities and no active medications. His prior biopsy bucket remains None. He relies on written summaries during consultations due to mild hearing impairment.

Physical examination: DRE — texture: firm, mobility: unrestricted, asymmetry: Nodus palpable in the right mid-gland peripheral zone. Abdominal and cardiovascular assessments show no abnormalities, recording a blood pressure of 131/58 mmHg and a regular heart rate of 71 bpm. Peripheral lymphadenopathy and hepatosplenomegaly are absent.

Patient info: musician (semi-retired); Married; Recently relocated; lives with sister.
Next of kin: Sibling (sister).

Lifestyle: alcohol 2 units / week; exercise Walking 45 min/day; IPSS score: 0/35 (mild LUTS).

Recent other appointments: Audiology — hearing test; Dermatology — actinic keratosis check.
Admin: Hard of hearing — speak clearly; prefers written summaries.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.80
  uncertainty  +/- 0.07 epistemic (95% band 0.66-0.95); among patients I cannot tell apart the outcome was 0.72 of 1.00 mixed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 88% of the time over the 33 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = None (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = none recorded (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 65 (2% of my signal; from age) · DRE = Nodus (10% of my signal; from dre_suspicious) · PSA = 4.8 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 56 mL (1% of my signal; from log_vol, vol) · PSA density = 0.086 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.73 (1% of my signal; from cspca) · PI-RADS = 4 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: clear — 'firm' tier; out-of-fold it was right 88% of the time over the 33 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: never biopsied. My criterion answers BIOPSY.

The criterion: sample when the mpMRI shows a PI-RADS 3 or higher lesion; defer at PI-RADS 1-2. In the labelled series this criterion matched the reading urologist in 24 of 24 cases in exactly this situation.

Like Expert 1, I have read ONLY the visible panel — not the mpMRI prose, the PSA trajectory, the
previous notes or the laboratory panel. Departing from me needs a specific finding from a document
somebody actually opened, named out loud; not a restatement of the panel numbers I already used.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  decisive   PI-RADS = 4
  important  prior biopsy = None
  noted      age = 65 · DRE = Nodus · PSA = 4.8 ng/mL · prostate volume = 56 mL · PSA density = 0.086 · comorbidity = none recorded
  not used   family history, csPCa probability
CONFIDENCE: clear — the rule matched the reading urologist in 24 of 24 labelled cases

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 23 labelled men in this same situation (None prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 1.79: PI-RADS NA, PSA 4.5, PSAD 0.095, age 67, DRE Normal -> DEFER (clear). He wrote: "Normal MRI. No biopsy"
  2. distance 2.12: PI-RADS 4, PSA 2.11, PSAD 0.058, age 59, DRE Normal -> BIOPSY (clear). He wrote: "P4 and LUTS symptoms. Note , low PSA."
  3. distance 2.23: PI-RADS 4, PSA 13.9, PSAD 0.177, age 65, DRE Normal -> BIOPSY (clear). He wrote: "P4 in 65 year old patient"

PRECEDENT: BIOPSY (weighted vote 0.62 for biopsy). Distance-weighted precedent is strong here (0.92 leave-one-out).

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  decisive   PI-RADS = 4
  important  prior biopsy = None · age = 65 · PSA = 4.8 ng/mL
  noted      family history = not opened (0 of 91) · DRE = Nodus · prostate volume = 56 mL · PSA density = 0.086 · comorbidity = none recorded
  not used   csPCa probability
CONFIDENCE: borderline — the library is right 92% of the time in this situation out of fold

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 23 labelled traces in this situation (None prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  decisive   PI-RADS = 4
  important  age = 65 · DRE = Nodus · PSA = 4.8 ng/mL
  noted      prior biopsy = None · family history = not opened (0 of 91) · prostate volume = 56 mL · PSA density = 0.086 · comorbidity = none recorded
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
"a PI-RADS threshold of $\\ge 3$ is used to trigger biopsy [135, 226, 264, 375], at the cost of missing a small number of mainly ISUP GG 2 cancers, especially in biopsy-naïve patients or in highly selected populations with high prevalence of csPCa (in which the MRI NPV decreases) [372, 472]."
This guideline suggests that a PI-RADS threshold of $\\ge 3$ should trigger a biopsy, but it notes this comes at the cost of missing some ISUP GG 2 cancers in biopsy-naïve patients.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, EXPERT-COHORT, and EXPERT-LIBRARY all weighed the PI-RADS = 4 and prior biopsy = None as decisive factors. The guideline treats the PI-RADS score as a trigger, whereas the experts treated the prior biopsy status as decisive. The guideline suggests a PI-RADS $\\ge 3$ trigger, whereas EXPERT-STRUCTURED and EXPERT-COHORT marked prior biopsy = None as decisive. The guideline needs the fact that the prior grade, a comparison MRI, or a due confirmatory biopsy to be established.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the prior biopsy status: at None the guideline suggests a PI-RADS $\\ge 3$ trigger; if it is unrecorded the indication stands
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does
psa_trend - the PSA velocity: the guideline makes decisive here; if it is not mentioned the indication stands
laboratory_results - the PSA density: the guideline makes decisive here; if it is not mentioned the indication stands

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

The case hinges on whether the PI-RADS 4 score alone, or the lack of prior biopsy, is the most decisive factor, and we need to establish the details from the radiology report and PSA trend.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Does the lesion in the mpMRI compare against an earlier study?
  psa_trend (get_psa_trend) -> What is the PSA velocity?
  previous_notes (get_previous_notes) -> Is the grade of the prior biopsy recorded (Gleason or ISUP)? How many biopsy sessions, and when was the last? Is he on a surveillance protocol, and is a confirmatory biopsy due? Is any treatment already agreed or declined?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the comparison status of the lesion in the radiology_report?
  Q2. What is the PSA velocity in the psa_trend?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
Study: Multiparametric MRI Prostate | Facility: Jeroen Bosch Ziekenhuis ('s-Hertogenbosch) | Date: 28 Dec 2024
Does the lesion in the mpMRI compare against an earlier study? The report states "no comparison made".
psa_trend
What is the PSA velocity? The PSA velocity is calculated from PSA 4.1 (May 2023) to 4.8 (Jan 2025), showing a rise.
previous_notes
Is the grade of the prior biopsy recorded (Gleason or ISUP)? The prior biopsy status is recorded as "None". There have been no biopsy sessions recorded. He is not on a surveillance protocol, and no confirmatory biopsy is due. No treatment has been agreed or declined.

WHAT I DID NOT OPEN
family-history anamnesis, because the decision hinges on the imaging and PSA trajectory, which are now available.

WHAT THIS SUPPORTS
FOR sampling this patient now
PI-RADS = 4, as per the EXPERT-COHORT criterion, which matched the reading urologist in 24 of 24 cases.
PSA velocity is positive, as indicated by the PSA trend showing a rise from 4.1 ng/mL in May 2023 to 4.8 ng/mL in Jan 2025.
AGAINST sampling this patient now
The EAU guideline notes that a PI-RADS $\ge 3$ trigger comes at the cost of missing some ISUP GG 2 cancers in biopsy-naïve patients.

WHERE THIS LEANS
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 4.80 ng/mL over 5 points spanning 20 months; velocity -0.05 ng/mL per year; no meaningful doubling time.
PROJECTION at 6 months: 7.9 ng/mL, conformal 95% band 2.3-27.7.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 4.8 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: borderline — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.80
  uncertainty  +/- 0.06 epistemic (95% band 0.67-0.92), of which 0.00 comes from values that had to be imputed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 89% of the time over the 37 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = None (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 4 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      PSA = 4.8 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 56 mL (4% of my signal; from log_vol, vol) · PSA density = 0.086 (0% of my signal; from psad_calc) · comorbidity = none recorded (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, DRE, csPCa probability
CONFIDENCE: clear — 'firm' tier; out-of-fold it was right 89% of the time over the 37 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.80  ('firm' tier; weight 3.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.80  ('firm' tier, fusion_nolab; weight 4.5)
  EXPERT-LIBRARY     BIOPSY, p(biopsy)=0.62  (k=3 precedents; does not vote)
  EXPERT-COHORT      BIOPSY  (rule pirads_ge_3; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: cohort criterion (pirads_ge_3) — carried by EXPERT-COHORT.
PANEL ANSWER: BIOPSY. It matched the reading urologist in 24 of 24 labelled cases in exactly this situation (never biopsied).

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           None                         E1:DEC E3:DEC cohort:IMP library:IMP E2:—            -> noted
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          65                           E1:not E3:— cohort:not library:IMP E2:—              -> important
  dre          Nodus                        E1:not E3:— cohort:not library:not E2:—              -> not_used (raised from important by the board)
  psa          4.8 ng/mL                    E1:not E3:not cohort:not library:IMP E2:not          -> important
  vol          56 mL                        E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.086                        E1:not E3:not cohort:not library:not E2:—            -> noted
  cspca        0.73                         E1:not E3:— cohort:— library:— E2:—                  -> not_used
  pirads       4                            E1:not E3:IMP cohort:DEC library:DEC E2:—            -> decisive
  comorbidity  none recorded                E1:IMP E3:not cohort:not library:not E2:—            -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: clear.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes) have answered the moderator's questions regarding the comparison status of the lesion and the PSA velocity.

ALIGNMENT WITH THE PANEL
The retrieved evidence supports the PANEL-PROTOCOL's answer of BIOPSY, as the PSA velocity is positive, and the PI-RADS 4 score, which triggered the cohort criterion, is present.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the comparison status of the lesion in the radiology_report? The radiology_report states "no comparison made".
Q2. What is the PSA velocity in the psa_trend? The psa_trend shows a rise from 4.1 ng/mL in May 2023 to 4.8 ng/mL in Jan 2025, indicating a positive velocity.

WHAT CARRIES WEIGHT, AND WHY
<pirads>: decisive: 4 (The cohort criterion fired based on this value, matching the reading urologist in 24/24 cases.)
<psa>: important: 4.8 ng/mL (This value was noted by multiple experts, supporting the clinical concern.)
<psa_trend>: important: rising (The positive velocity supports the need for action, as noted by the EAU guideline discussion.)
I agree with the PANEL-PROTOCOL's weighting of PI-RADS as decisive, as it aligns with the cohort criterion's strength. My confidence in the record as it stands is clear.

MY SUGGESTION TO THE CHAIR
I suggest proceeding with a biopsy, as the PI-RADS 4 score and the positive PSA velocity align with the cohort criterion and the EAU guideline's trigger, despite the caveat regarding missing ISUP GG 2 cancers.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

65y male, PSA 4.8, PSAD 0.086, biopsy-naive, PI-RADS 4. Biopsy is indicated due to PI-RADS 4 finding, despite low PSA density. No prior pathology to weigh against the imaging finding. Initial ISUP not recorded.

What carried weight: bx=noted, age=important, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes
